INSM Dividend History & Analysis | N/A Yield
INSM has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| BTX | 1,397 M | 13.4% | 7.37% |
| ABBV | 393,809 M | 3.62% | 9.74% |
| GILD | 150,721 M | 2.52% | 6.73% |
| AMGN | 174,694 M | 2.87% | 4.98% |
| HLN | 44,084 M | 1.74% | 2.46% |
| Symbol | Market Cap USD | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| BTX | 1,397 M | 203% | 90.0% |
| GRFS | 7,645 M | 127% | 56.8% |
| HLN | 44,084 M | 51.0% | 100% |
| AMGN | 174,694 M | 8.90% | 100% |
| ABBV | 393,809 M | 7.06% | 100% |
Similar Stocks with Attractive Dividends - Compare INSM Dividends with its Peer-Group
3.62% Yield
2.87% Yield
2.52% Yield
1.74% Yield
INSM Dividend History: as of December 2025
No dividends paid yet.INSM Dividend FAQ
Insmed Inc. (NASDAQ: INSM) focuses on developing and commercializing therapies for rare, serious respiratory diseases. Its only currently marketed product, ARIKAYCE (liposomal amikacin), is approved for refractory nontuberculous mycobacterial (NTM) lung infections, and the company is pursuing a Phase 3 trial of a combination regimen for Mycobacterium avium complex (MAC) disease. The pipeline also includes brensocatib (a reversible DPP-1 inhibitor) in Phase 3 for bronchiectasis and Phase 2 for chronic rhinosinusitis without polyps and hidradenitis suppurativa, as well as treprostinil palmitil inhalation powder in Phase 3 for pulmonary hypertension associated with interstitial lung disease and Phase 2 for pulmonary arterial hypertension. Early-stage programs span a micro-dystrophin AAV gene therapy for Duchenne muscular dystrophy and next-generation DPP-1 inhibitors.
What is the Dividend Yield of INSM?
As of December 2025, INSM`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 176.77.Does INSM pay a dividend?
As of December 2025 INSM does not pay a dividend.How often does INSM pay dividends?
Over the last 12 months, INSM has issued dividend payments.INSM dividend forecast
Based on historical data, the forecasted dividends per share for INSM for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will INSM pay dividends in 2025?
The next Ex-Dividend date for Insmed (INSM) is currently unknown.What is the next Ex-Dividend Date for INSM?
The next Ex-Dividend date for Insmed (INSM) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of INSM?
INSM's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of INSM?
INSM's 5-Year Yield on Cost is -%. If you bought INSM's shares at 34.10 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of INSM?
INSM Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does INSM have a good Dividend Yield?
INSM`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of INSM?
The Dividend Payout Ratio of INSM is unknown.What is the Dividend Rating of INSM?
INSM`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-12-22 04:42